Yun-ye Liu

Insulin sensitizes FGF21 in glucose and lipid metabolisms via activating common AKT pathway

Dan Yu, X. Ye, Qiang Wu, 2016, Endocrine.

Recombinant Newcastle disease virus (NDV/Anh-IL-2) expressing human IL-2 as a potential candidate for suppresses growth of hepatoma therapy.

Qingzhong Yu, X. Ye, J. Qi, 2016, Journal of pharmacological sciences.

Canine Fibroblast Growth Factor 21 Ameliorates Hyperglycemia Associated with Inhibiting Hepatic Gluconeogenesis and Improving Pancreatic Beta-Cell Survival in Diabetic Mice and Dogs

Qiang Wu, Liying Song, G. Ren, 2016, PloS one.

Fibroblast growth factor 21 (FGF21) inhibits macrophage-mediated inflammation by activating Nrf2 and suppressing the NF-κB signaling pathway.

Liying Song, Xiaochen Guo, G. Ren, 2016, International immunopharmacology.

Recombinant NDV expressing cytokines or fliC confers a quick immune response against NDV challenge and resistance to maternal antibody.

Xu Zhang, G. Ren, Deshan Li, 2016, Veterinary microbiology.

FGF21 treatment ameliorates alcoholic fatty liver through activation of AMPK-SIRT1 pathway.

Bing Zhou, X. Ye, G. Ren, 2014, Acta biochimica et biophysica Sinica.

A recombinant avian antibody against VP2 of infectious bursal disease virus protects chicken from viral infection.

Xiaomei Wang, X. Qi, X. Ye, 2017, Research in veterinary science.